The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interferon signaling and outcomes in triple-negative breast cancer (TNBC) in FinXX, CALGB 40603 (Alliance) and real-world clinico-genomic data.
 
Saranya Chumsri
Honoraria - Roche Thailand
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Athenex; Axiom Healthcare Strategies; bioTheranostics; bioTheranostics (Inst); Cardinal Health; Cepton Strategies; Daiichi Sankyo/Astra Zeneca; Eisai; Equinox Group; Eradigm Consulting; Genentech; Gilead Sciences; Immunomedics; Immunomedics; Immunomedics; MDoutlook; Novartis; Novartis; Novartis (Inst); Puma Biotechnology; Seagen; Syndax
Research Funding - Array BioPharma; Briacell (Inst); Merck; Salix
 
Yi Liu
No Relationships to Disclose
 
Sachin Kumar Deshmukh
Employment - Caris Life Sciences
 
Jodi Carter
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Heikki Joensuu
No Relationships to Disclose
 
Roberto Leon-Ferre
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Lyell Immunopharma (Inst); Merck (Inst)
 
David Zahrieh
Employment - Ultragenyx Pharmaceuticals
Stock and Other Ownership Interests - Ultragenyx Pharmaceuticals
 
Judy Boughey
Honoraria - UpToDate
Consulting or Advisory Role - CairnSurgical; SymBioSis (Inst)
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
James Ingle
No Relationships to Disclose
 
Fergus Couch
Employment - Mayo Clinic
Honoraria - Ambry Genetics/Konica Minolta
Consulting or Advisory Role - AstraZeneca
Research Funding - GRAIL (Inst)
 
Evanthia Roussos Torres
No Relationships to Disclose
 
Maryam Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Menarini; Novartis; Osmol Therapeutics; Pfizer
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic
 
Daniel Stover
Consulting or Advisory Role - Guardant Health; Natera
Research Funding - Foundation Medicine (Inst); NeoGenomics Laboratories (Inst)
Patents, Royalties, Other Intellectual Property - Intellectual Property Related to Cancer Diagnostics
 
William Sikov
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Lilly; Seagen
Travel, Accommodations, Expenses - AstraZeneca
 
Ann Partridge
Patents, Royalties, Other Intellectual Property - Wolters Kluwer- royalties for authorship of UpToDate
 
Lisa Carey
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); Lilly (Inst); NanoString Technologies (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Veracyte (Inst)
(OPTIONAL) Uncompensated Relationships - Reveal Genomics
 
George Sledge
Employment - Caris Life Sciences
Leadership - Caris Life Sciences; Syndax
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Matthew Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); ARC Therapeutics (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Atossa Therapeutics (Inst); BeiGene (Inst); bioTheranostics (Inst); BioTheryX; Biovica (Inst); Blueprint Medicines (Inst); Context Therapeutics (Inst); Eagle Pharmaceuticals (Inst); eChinaHealth (Inst); EcoR1 Capital (Inst); Engage Health Media (Inst); Genentech (Inst); Genomic Health (Inst); Genzyme (Inst); Genzyme (Inst); Incyclix Bio (Inst); Intellisphere (Inst); Laekna Therapeutics; Lilly (Inst); Loxo (Inst); Novartis (Inst); Puma Biotechnology (Inst); Rna Diagnostics (Inst); Seagen (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Sermonix Pharmaceuticals (Inst); Tersera
Research Funding - AstraZeneca (Inst); Atossa Genetics (Inst); BioTheryX (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst); SimBioSys (Inst)
Travel, Accommodations, Expenses - Lilly (Inst)
(OPTIONAL) Uncompensated Relationships - Symbios
 
Keith Knutson
Leadership - AffyImmune Therapeutics; Kiromic
Stock and Other Ownership Interests - Kiromic
Research Funding - Marker Therapeutics
Patents, Royalties, Other Intellectual Property - Mayo Clinic holds several patents of technologies that I have developed.
 
E Thompson
No Relationships to Disclose